Urgent Recall: Over 11,000 Bottles of Blood Pressure Meds Recalled

URGENT UPDATE: Over 11,000 bottles of a widely used blood pressure medication have been urgently recalled due to potential contamination. The U.S. Food and Drug Administration (FDA) confirmed that the recall involves Bisoprolol Fumarate and Hydrochlorothiazide Tablets, branded as Ziac, manufactured by Glenmark Pharmaceuticals Inc..

The recall, initiated on November 21, affects 11,136 bottles distributed nationwide, including 30-count, 100-count, and 500-count sizes. Testing of reserve samples revealed traces of ezetimibe, a cholesterol medication produced by the same company, indicating possible cross-contamination.

The affected lot numbers and their respective expiration dates are as follows:
– Lot 17232401, exp 11/2025
– Lot 17240974, exp 05/2026

Officials have classified the recall as a Class III risk level, indicating that exposure to the contaminated product is not likely to cause adverse health consequences. However, consumers are urged to check their medication bottles immediately.

This recall highlights the importance of vigilance regarding medication safety. Patients using these blood pressure tablets should consult their healthcare providers for alternatives and to discuss any potential risks associated with the contamination.

The FDA continues to monitor the situation, and the recall remains ongoing. Health officials emphasize that consumers should be aware of this urgent recall to prevent any health complications.

Stay tuned for more updates as this story develops. Share this information with family and friends who may be affected!